PCVaxcyte PCVX · NASDAQ
$63.68 +0.09% (+$0.06)
- Market cap
- $9.76B
- Enterprise value
- $9.69B
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- -
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -40.6%
- Bruto marža
- -
- Neto marža
- -
- Dividend yield
- -
- Payout ratio
- -
- Neto dolg/EBITDA
- -
- Beta
- 1.23
- Free float
- 89.4%
O podjetju
Vaxcyte is an American biotechnology company focused on developing vaccines for the prevention of serious infectious diseases. The company specializes in advanced vaccine technologies, including cellular therapies and protein-based vaccines, with the aim of providing effective protection against pathogens that currently lack sufficient vaccines. Vaxcyte is developing vaccines for infections such as pneumococcal disease and is working to improve immunization and the prevention of infectious diseases globally.
Sector
Healthcare
Industry
Biotechnology
CEO
Grant E. Pickering
Employees
507
Headquarters
San Carlos
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke